Aerovate Therapeutics (AVTE) Short Interest Ratio & Short Volume $2.56 -0.07 (-2.66%) (As of 11/14/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Aerovate Therapeutics Short Interest DataAerovate Therapeutics (AVTE) has a short interest of 549,800 shares, representing 2.81% of the float (the number of shares available for trading by the public). This marks a -17.32% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 618,545 shares to cover all short positions.Current Short Interest549,800 sharesPrevious Short Interest665,000 sharesChange Vs. Previous Month-17.32%Dollar Volume Sold Short$1.35 millionShort Interest Ratio0.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares28,870,000 sharesFloat Size19,580,000 sharesShort Percent of Float2.81%Today's Trading Volume442,421 sharesAverage Trading Volume618,545 sharesToday's Volume Vs. Average72% Short Selling Aerovate Therapeutics? Sign up to receive the latest short interest report for Aerovate Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVTE Short Interest Over TimeAVTE Days to Cover Over TimeAVTE Percentage of Float Shorted Over Time Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Aerovate Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024549,800 shares $1.35 million -17.3%2.8%0.7 $2.45 10/15/2024665,000 shares $1.40 million -21.4%3.4%2.8 $2.11 9/30/2024846,500 shares $1.77 million -20.9%4.3%3 $2.09 9/15/20241,070,000 shares $2.03 million -15.8%5.5%2 $1.90 8/31/20241,270,000 shares $2.45 million +9.5%6.5%1.1 $1.93 8/15/20241,160,000 shares $2.08 million +23.5%5.9%1 $1.79 Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024939,000 shares $1.71 million +11.4%4.9%0.8 $1.82 7/15/2024842,600 shares $1.60 million -6.4%4.4%0.8 $1.90 6/30/2024900,400 shares $1.49 million -57.7%4.7%0.8 $1.66 6/15/20242,130,000 shares $52.44 million -3.6%11.1%2.3 $24.62 5/31/20242,210,000 shares $38.56 million +0.9%11.7%10.7 $17.45 5/15/20242,190,000 shares $46.01 million +16.5%12.0%13.1 $21.01 4/30/20241,880,000 shares $37.62 million +50.4%10.4%13.1 $20.01 4/15/20241,250,000 shares $31.63 million +25.9%7.2%8.3 $25.30 3/31/2024993,100 shares $29.37 million +9.9%5.8%7.6 $29.57 3/15/2024903,700 shares $24.13 million -10.5%5.3%8.8 $26.70 2/29/20241,010,000 shares $23.31 million -9.8%5.9%10.7 $23.08 2/15/20241,120,000 shares $24.24 million +5.7%6.6%11.7 $21.64 1/31/20241,060,000 shares $20.47 million +11.3%6.2%11.8 $19.31 1/15/2024952,100 shares $19.13 million -0.8%5.6%12.6 $20.09 12/31/2023959,300 shares $21.71 million -12.0%5.6%11.7 $22.63 12/15/20231,090,000 shares $19.62 million -10.7%6.4%13.2 $18.00 11/30/20231,220,000 shares $19.17 million -5.4%7.2%16.1 $15.71 11/15/20231,290,000 shares $18.80 million +4.9%7.6%17.8 $14.57 10/31/20231,230,000 shares $13.05 million -8.9%7.1%16.9 $10.61 10/15/20231,350,000 shares $14.85 million -12.3%7.8%18.3 $11.00 9/30/20231,540,000 shares $20.90 million +7.7%8.9%21.3 $13.57 9/15/20231,430,000 shares $18.80 million +5.9%8.3%20 $13.15 8/31/20231,350,000 shares $21.45 million +3.9%7.8%15.9 $15.89 8/15/20231,300,000 shares $19.21 million +4.8%7.5%14.6 $14.78 7/31/20231,240,000 shares $21.64 million +2.5%7.3%14.8 $17.45 7/15/20231,210,000 shares $22.08 million +9.0%7.1%13.9 $18.25 6/30/20231,110,000 shares $19.04 million No Change6.5%12.6 $17.15 6/15/20231,110,000 shares $18.76 million +15.4%6.5%12.2 $16.90 5/31/2023961,900 shares $15.63 million +5.3%6.2%12.3 $16.25 5/15/2023913,900 shares $19.27 million -5.3%5.9%12.6 $21.08 4/30/2023965,000 shares $20.24 million +1.4%6.1%13.5 $20.97 4/15/2023951,300 shares $16.07 million +10.2%6.0%10.3 $16.89 3/31/2023862,900 shares $17.40 million -7.4%5.5%8.9 $20.17 3/15/2023932,200 shares $20.49 million -4.4%5.6%9.6 $21.98Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad)Cash In On the Pro-Crypto America 27 experts reveal their top picks for 2025 Click here to reserve your seat at the Crypto Community Summit. 2/28/2023974,600 shares $23.95 million +1.5%5.9%7.2 $24.57 2/15/2023960,000 shares $25.32 million -53.2%5.8%6.3 $26.37 1/31/20232,050,000 shares $46.84 million +0.5%12.4%13 $22.85 1/15/20232,040,000 shares $51.10 million +9.1%12.3%15.5 $25.05 12/30/20221,870,000 shares $54.79 million +11.3%11.3%14.9 $29.30 12/15/20221,680,000 shares $43.09 million +33.3%10.3%13.7 $25.65 11/30/20221,260,000 shares $23.74 million -14.3%7.7%12.2 $18.84 11/15/20221,470,000 shares $28.62 million -3.3%9.0%17.2 $19.47 10/31/20221,520,000 shares $29.66 million +0.7%9.1%21 $19.51 10/15/20221,510,000 shares $29.25 million +2.0%9.1%18 $19.37 9/30/20221,480,000 shares $24.54 million -1.3%8.9%14.4 $16.58 9/15/20221,500,000 shares $23.76 million No Change9.0%13.7 $15.84 8/31/20221,500,000 shares $29.75 million -2.6%9.0%14.8 $19.83 8/15/20221,540,000 shares $39.33 million +10.0%9.3%15.1 $25.54 7/31/20221,400,000 shares $31.15 million +45.4%8.2%13.6 $22.25 7/15/2022963,200 shares $17.34 million +7.6%5.7%11 $18.00 6/30/2022895,600 shares $14.00 million +20.5%6.6%13 $15.63 6/15/2022743,100 shares $9.14 million +6.7%5.5%10.4 $12.30 5/31/2022696,300 shares $8.46 million +17.9%5.1%11.1 $12.15 5/15/2022590,600 shares $7.72 million +17.0%4.3%9.4 $13.07 4/30/2022505,000 shares $6.44 million +3.6%3.0%8.7 $12.75 4/15/2022487,500 shares $8.21 million +4.8%2.9%9.2 $16.84 3/31/2022465,200 shares $8.53 million +6.0%2.8%9 $18.33 3/15/2022438,800 shares $5.27 million +7.1%2.7%8.8 $12.00 2/28/2022409,600 shares $4.01 million -3.7%2.5%7.3 $9.78 2/15/2022425,300 shares $4.32 million -0.6%2.6%7.2 $10.15 1/31/2022427,900 shares $5.06 million -0.7%2.6%6.1 $11.82 1/15/2022431,100 shares $4.09 million -3.4%2.5%6.1 $9.49 12/31/2021446,200 shares $5.26 million -0.2%2.6%3.9 $11.79 12/15/2021446,900 shares $5.51 million +17.7%2.6%3.8 $12.34 11/30/2021379,600 shares $5.20 million +4.4%2.2%2.6 $13.71 11/15/2021363,700 shares $6.35 million -3.3%2.1%2.3 $17.46 10/29/2021376,200 shares $5.99 million +13.7%2.2%2.4 $15.93 10/15/2021330,900 shares $4.68 million -70.2%2.0%2.2 $14.13 9/30/20211,110,000 shares $23.29 million +30.7%6.5%9.6 $20.98 9/15/2021849,100 shares $18.31 million +13.5%5.0%6.1 $21.56 8/31/2021747,900 shares $12.78 million +1.7%4.4%6.8 $17.09 8/13/2021735,600 shares $9.20 million No Change4.6%7.6 $12.50 AVTE Short Interest - Frequently Asked Questions What is Aerovate Therapeutics' current short interest? Short interest is the volume of Aerovate Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 549,800 shares of AVTE short. 2.81% of Aerovate Therapeutics' shares are currently sold short. Learn More on Aerovate Therapeutics' current short interest. What is a good short interest ratio for Aerovate Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVTE shares currently have a short interest ratio of 1.0. Learn More on Aerovate Therapeutics's short interest ratio. Which institutional investors are shorting Aerovate Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aerovate Therapeutics: LMR Partners LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aerovate Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.81% of Aerovate Therapeutics' floating shares are currently sold short. Is Aerovate Therapeutics' short interest increasing or decreasing? Aerovate Therapeutics saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 549,800 shares, a drop of 17.3% from the previous total of 665,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aerovate Therapeutics' float size? Aerovate Therapeutics currently has issued a total of 28,870,000 shares. Some of Aerovate Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aerovate Therapeutics currently has a public float of 19,580,000 shares. How does Aerovate Therapeutics' short interest compare to its competitors? 2.81% of Aerovate Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aerovate Therapeutics: CytomX Therapeutics, Inc. (7.25%), Immunic, Inc. (5.00%), Gossamer Bio, Inc. (2.78%), Zura Bio Limited (4.14%), AC Immune SA (1.59%), biote Corp. (2.70%), Lyell Immunopharma, Inc. (8.93%), Biomea Fusion, Inc. (30.19%), UroGen Pharma Ltd. (28.14%), Immutep Limited (3.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Aerovate Therapeutics stock? Short selling AVTE is an investing strategy that aims to generate trading profit from Aerovate Therapeutics as its price is falling. AVTE shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aerovate Therapeutics? A short squeeze for Aerovate Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVTE, which in turn drives the price of the stock up even further. How often is Aerovate Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVTE, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies CytomX Therapeutics Short Interest Data Immunic Short Interest Data Gossamer Bio Short Interest Data Zura Bio Short Interest Data AC Immune Short Interest Data biote Short Interest Data Lyell Immunopharma Short Interest Data Biomea Fusion Short Interest Data UroGen Pharma Short Interest Data Immutep Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVTE) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVTE Stock Alerts